Echopoint Medical aim to transform coronary diagnostics by providing a complete picture of coronary physiology.

The iKOr microcatheter system enables cardiologists to accurately diagnose complex heart conditions.

Successful First-in-Human trials at Barts, London, demonstrate safety and efficacy, and multiple pre-clinical studies demonstrate the accuracy and ease of use of the iKOr system.

By giving clinicians deeper insights into what is happening inside the arteries, Echopoint Medical enable more informed decisions and tailored treatments that lead to better patient outcomes. Better insights for clinicians means better outcomes for patients.

Echopoint Medical is led by a seasoned executive team with proven track records in MedTech commercialisation and strategic exit. The market for coronary diagnostics is over $2bn market, with 9% CAGR, driven by unmet needs in diagnosing microvascular disease.